News | August 16, 2007

Bard Receives FDA Approval for Endovascular Stent Graft

August 17, 2007 – C. R. Bard Inc. announced that it has received FDA approval to market its FLAIR Endovascular Stent Graft to treat stenoses (narrowing) at the venous anastomosis of synthetic arteriovenous (AV) grafts in hemodialysis patients to increase blood flow.
The FLAIR Endovascular Stent Graft is a flexible, self-expanding stent graft made of expanded ePTFE covering a Nitinol stent framework. Bard’s Peripheral Vascular Division, located in Tempe, AZ, is currently in discussions with the FDA on a post-approval study design utilizing a new FLAIR delivery system. The initial market launch for the FLAIR Endovascular Stent Graft is expected in late 2008, following FDA approval of the new FLAIR delivery system.
“The FLAIR Endovascular Stent Graft is the first interventional technology that has demonstrated superiority to balloon angioplasty for maintaining access patency," said Ziv Haskal, M.D., of New York Presbyterian/Columbia University Medical Center. Dr. Haskal was the lead investigator of the randomized, prospective, multi-center clinical trial to evaluate the safety and effectiveness of the device. One hundred 90 patients with a hemodynamically significant stenosis; 50% at the synthetic AV access graft-vein-anastomosis were randomized to treatment with PTA, followed by the placement of a FLAIR Endovascular Stent Graft, or to treatment with PTA alone.
Results of the clinical trial demonstrated that the FLAIR Endovascular Stent Graft was superior to the PTA Control with respect to the primary effectiveness endpoint, six month Treatment Area Primary Patency (51% vs 23%; p

For more information:

Related Content

Vital Images Inc., AAA, fenestrated stents, endovascular stent planning, Vitrea

Image courtesy of Vital Images Inc.

Technology | December 23, 2014
Vital Images Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Fenestrated Stent...
Technology | March 14, 2011
March 14, 2011 – A vascular graft for hemodialysis access has received the CE mark. The Gore Propaten vascular graft,...
News | November 24, 2010
November 24, 2010 - Rotational computed tomography angiography (CTA), a new noninvasive imaging modality, has the...
Technology | June 14, 2010
June 14, 2010 – A new Internet, cloud-based, 3-D advanced visualization and decision support system aids physicians in...
Technology | November 20, 2009
November 20, 2009 – A new service for endovascular specialists who treat aortic aneurysms converts 2D computed...
News | August 16, 2007
August 17, 2007 - DocuSys Inc., a leading provider of anesthesia information management systems (AIMS) and drug mana
News | August 16, 2007
August 17, 2007 - Richard J. Rosenbluth, M.
News | January 28, 2007
January 29, 2007 - DMS Health Technologies, a member of the DMS Health Group and a national diagnostic imaging and e
News | December 18, 2006
The AP reports that states and communities around the nation are developing creative readiness strategies in preparat